Literature DB >> 30419105

Is Precision Medicine an Oxymoron?

S Gail Eckhardt1, Christopher Lieu2.   

Abstract

Year:  2019        PMID： 30419105     DOI： 10.1001/jamaoncol.2018.5099

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  11 in total

Review 1.  Promises, promises, and precision medicine.

Authors:  Michael J Joyner; Nigel Paneth
Journal:  J Clin Invest       Date:  2019-01-28       Impact factor: 14.808

2.  Introduction by the Guest Editor: Oncologic Precision Medicine and the Use of Basket and Umbrella Clinical Trials.

Authors:  James H Doroshow
Journal:  Cancer J       Date:  2019 Jul/Aug       Impact factor: 3.360

3.  From the Broad Phase II Trial to Precision Oncology: A Perspective on the Origins of Basket and Umbrella Clinical Trial Designs in Cancer Drug Development.

Authors:  Deborah B Doroshow; James H Doroshow
Journal:  Cancer J       Date:  2019 Jul/Aug       Impact factor: 3.360

Review 4.  Genomics and the History of Precision Oncology.

Authors:  Deborah B Doroshow; James H Doroshow
Journal:  Surg Oncol Clin N Am       Date:  2019-10-29       Impact factor: 3.495

Review 5.  Perspectives on metals-based radioimmunotherapy (RIT): moving forward.

Authors:  Jordan M White; Freddy E Escorcia; Nerissa T Viola
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

6.  Mapping actionable pathways and mutations in brain tumours using targeted RNA next generation sequencing.

Authors:  Krissie Lenting; Corina N A M van den Heuvel; Anne van Ewijk; Duaa ElMelik; Remco de Boer; Elizabeth Tindall; Ge Wei; Benno Kusters; Maarten Te Dorsthorst; Mark Ter Laan; Martijn A Huynen; William P Leenders
Journal:  Acta Neuropathol Commun       Date:  2019-11-20       Impact factor: 7.801

Review 7.  Personalized Medicine: Recent Progress in Cancer Therapy.

Authors:  Valentina Gambardella; Noelia Tarazona; Juan Miguel Cejalvo; Pasquale Lombardi; Marisol Huerta; Susana Roselló; Tania Fleitas; Desamparados Roda; Andres Cervantes
Journal:  Cancers (Basel)       Date:  2020-04-19       Impact factor: 6.639

8.  ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors.

Authors:  Freddy E Escorcia; Jacob L Houghton; Dalya Abdel-Atti; Patricia R Pereira; Andrew Cho; Nicholas T Gutsche; Kwamena E Baidoo; Jason S Lewis
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

Review 9.  Molecular profiling for precision cancer therapies.

Authors:  Eoghan R Malone; Marc Oliva; Peter J B Sabatini; Tracy L Stockley; Lillian L Siu
Journal:  Genome Med       Date:  2020-01-14       Impact factor: 11.117

10.  Toward improved models of human cancer.

Authors:  Bryan E Welm; Christos Vaklavas; Alana L Welm
Journal:  APL Bioeng       Date:  2021-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.